The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

Kennedy’s FDA approved the use of the Novavax Covid-19 vaccine, but with strict conditions. It will only be made available to older people and those over the age of 12 with at least one medical ...

After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...

The Novavax Covid-19 vaccine, which uses more traditional protein-based technology than the mRNA vaccines from ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...